Centene Corporation (BIT:1CNC)
Italy · Delayed Price · Currency is EUR | Market Cap | 24.97B -10.0% |
| Revenue (ttm) | 154.67B +16.4% |
| Net Income | -5.59B |
| EPS | -11.36 |
| Shares Out | n/a |
| PE Ratio | n/a |
| Forward PE | 15.96 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 120 |
| Open | 49.00 |
| Previous Close | 49.96 |
| Day's Range | 49.00 - 50.22 |
| 52-Week Range | 19.34 - 53.64 |
| Beta | n/a |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Jul 28, 2026 |
About Centene
Centene Corporation operates as a managed care company that provides programs and services to under-insured families, and commercial organizations in the United States. It operates through four segments: Medicaid, Medicare, Commercial, and Other. The Medicaid segment offers the temporary assistance for needy families; medicaid expansion; aged, blind, or disabled; and children's health insurance programs, as well as long-term services and supports; foster care; and medicare-medicaid plans. This segment also provides healthcare products and servi... [Read more]
News
BofA adds Centene to ‘US 1 List,’ removes Cigna
BofA analysts added Centene (CNC) to the firm’s “US 1 List” while removing Cigna (CI). The list is a collection of BofA’s best investment ideas.
Five Stars: Health Net Recognized by USA TODAY for Customer Service; Only California-Based Health Insurer Recognized with Highest Rating
"America's Best Customer Service in Financial Services 2026" award recognizes companies delivering strong customer service based on nationwide consumer feedback SACRAMENTO, Calif., May 26, 2026 /PRNew...
Centene price target raised to $75 from $63 at Barclays
Barclays raised the firm’s price target on Centene (CNC) to $75 from $63 and keeps an Overweight rating on the shares. The firm believes the managed care stock moves post…
Centene price target raised to $61 from $55 at UBS
UBS analyst AJ Rice raised the firm’s price target on Centene (CNC) to $61 from $55 and keeps a Neutral rating on the shares. Managed care organizations broadly raised guidance…
Centene price target raised to $72 from $60 at BofA
BofA raised the firm’s price target on Centene (CNC) to $72 from $60 and keeps a Buy rating on the shares. The firm is “bullish” on and Molina Healthcare (MOH)…
Centene upgraded to Buy from Hold at Deutsche Bank
Deutsche Bank upgraded Centene (CNC) to Buy from Hold with a price target of $80, up from $53. The firm upgraded three managed care names citing a stabilizing managed care…
Centene price target raised to $58 from $50 at Mizuho
Mizuho analyst Ann Hynes raised the firm’s price target on Centene (CNC) to $58 from $50 and keeps a Neutral rating on the shares. The firm views the Q1 reports…
Centene upgraded to Buy from Hold at Deutsche Bank
Deutsche Bank upgraded Centene (CNC) to Buy from Hold with an $80 price target
Easing medical costs a positive for health insurers, but real test lies ahead, analysts say
U.S. health insurers' strong first-quarter results signaled more stable medical costs after prolonged pressure, but Wall Street analysts want to see another similar quarter before they are convinced.
Superior HealthPlan Awards $100,000 in Grants to 10 Community-based Organizations in Texas
The funding is made available through an annual program that addresses barriers to healthcare. AUSTIN, Texas, May 12, 2026 /PRNewswire/ -- Superior HealthPlan ("Superior"), a leading managed care orga...
Health Insurers Performing Better But There's Potential Trouble Ahead
Health insurance companies including UnitedHealthcare, CVS Health's Aetna, Centene and Blue Cross and Blue Shield plans owned by Elevance Health are seeing lower costs from patients submitting claims.
Centene price target raised to $48 from $38 at TD Cowen
TD Cowen raised the firm’s price target on Centene (CNC) to $48 from $38 and keeps a Hold rating on the shares. The firm updated its model following Q1 results…
Centene price target raised to $46 from $37 at Baird
Baird analyst MichaThe firm updated its model following Q1 resultsel Ha raised the firm’s price target on Centene (CNC) to $46 from $37 and keeps a Neutral rating on the…
Early notable gainers among liquid option names on April 29th
Notable gainers among liquid option names this morning include NXP Semiconductors (NXPI) $286.23 +55.84, Seagate (STX) $675.55 +96.52, Generac (GNRC) $242.79 +25.67, Western Digital (WDC) $429.35 +38....
Centene price target raised to $55 from $42 at UBS
UBS raised the firm’s price target on Centene (CNC) to $55 from $42 and keeps a Neutral rating on the shares. Centene’s prudent approach to guidance suggests further upside is…
Centene price target raised to $58 from $49 at Truist
Truist raised the firm’s price target on Centene (CNC) to $58 from $49 and keeps a Buy rating on the shares after its Q1 earnings beat. The company’s cash flow…
Centene price target raised to $40 from $32 at Goldman Sachs
Goldman Sachs analyst Scott Fidel raised the firm’s price target on Centene (CNC) to $40 from $32 and keeps a Sell rating on the shares. Centene rallied after a Q1…
Centene price target raised to $58 from $45 at Oppenheimer
Oppenheimer raised the firm’s price target on Centene (CNC) to $58 from $45 and keeps an Outperform rating on the shares. The firm says Centene’s Q1 results provided a very…
Centene double upgraded to Buy from Underperform at BofA
As previously reported, BofA double upgraded Centene (CNC) to Buy from Underperform with a price target of $60, up from $34, due to Medicaid margins likely bottoming in 2026. The…
Centene upgraded to Buy from Underperform at BofA
BofA upgraded Centene (CNC) to Buy from Underperform with a price target of $60, up from $34.
Centene stock rises as earnings beat, outlook lifted on cost cuts
Shares of Centene Corporation rose about 14% on Tuesday after the company reported stronger-than-expected first-quarter results, driven by cost controls and steady premium growth. The St. Louis-based ...
Centene Earnings Call Transcript: Q1 2026
Q1 2026 delivered strong EPS and revenue growth, driven by Medicaid and Medicare outperformance and disciplined cost management. Full-year EPS guidance was raised, with Marketplace margins conservatively set pending further risk adjustment data.
Centene Quarterly report: Q1 2026
Centene has published its Q1 2026 quarterly earnings report on April 28, 2026.
Centene Earnings release: Q1 2026
Centene released its Q1 2026 earnings on April 28, 2026, summarizing the period's financial results.